Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect
In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story
wh0cd946301 zoloft viagra gel furosemide tablet mobic 7.5 alli slimming pills fluoxetine synthroid buy propecia phenergan on line
Post your comment.